Table 2.
Risks of CHD and stroke among patients with T2DM according to CKD stage (%)
| Items | No CKD (n = 853) | CKD Stages 1–2 (n = 428) | CKD Stages 3–5 (n = 120) | F | P |
|---|---|---|---|---|---|
| CHD risk | 15.2 (9.6–25.3) | 20.1 (11.2–33.9)* | 28.5 (18.0–48.9)*,† | 40.946 | 0.000 |
| Fatal CHD risk | 5.1 (9.6–18.6) | 14.6 (7.0–27.9)* | 23.2 (12.8–42.7)*,† | 52.517 | 0.000 |
| Stroke risk | 4.5 (2.0–10.4) | 7.3 (3.0–16.4)* | 19.5 (8.6–34.7)*,† | 75.408 | 0.000 |
| Fatal stroke risk | 0.6 (0.3–1.5) | 1.2 (0.4–2.9)* | 3.1 (1.3–6.4)*,† | 87.225 | 0.000 |
*P<0.001 compared to cases no CKD; †P<0.001 compared to cases in CKD Stages 1–2. Data are expressed as median (25th–75th percentiles). CHD: Coronary heart disease; CKD: Chronic kidney disease; T2DM: Type 2 diabetes mellitus.